Kimia Therapeutics Appoints Imran S. Haque, Ph.D. as Chief Technology Officer Portfolio News / By Libby Nunan Kimia Therapeutics Appoints Imran S. Haque, Ph.D. as Chief Technology Officer Read More »
Tenaya Therapeutics Reports Fourth Quarter and Full Year 2024 Financial Results and Provides Business Update Portfolio News / By Karina Tin Tenaya Therapeutics Reports Fourth Quarter and Full Year 2024 Financial Results and Provides Business Update Read More »
RAPT Therapeutics Reports Fourth Quarter and Full Year 2024 Financial Results Portfolio News / By Karina Tin RAPT Therapeutics Reports Fourth Quarter and Full Year 2024 Financial Results Read More »
Tenaya Therapeutics Announces Pricing of Public Offering Portfolio News / By Karina Tin Tenaya Therapeutics Announces Pricing of Public Offering Read More »
Eikon Therapeutics Secures $350.7 Million Series D to Advance Clinical-Stage Programs and Future Pipeline Portfolio News / By Karina Tin Eikon Therapeutics Secures $350.7 Million Series D to Advance Clinical-Stage Programs and Future Pipeline Read More »
ORIC® Pharmaceuticals Announces Focused Registrational Clinical Development Plans for Lead Programs, Extended Cash Runway, and Updated Corporate Milestones Portfolio News / By Karina Tin ORIC® Pharmaceuticals Announces Focused Registrational Clinical Development Plans for Lead Programs, Extended Cash Runway, and Updated Corporate Milestones Read More »
NGM Bio Announces First Participant Dosed in EMERALD Phase 2 Clinical Study of NGM120 for the Treatment of Hyperemesis Gravidarum (HG) in Pregnant Patients Portfolio News / By Karina Tin NGM Bio Announces First Participant Dosed in EMERALD Phase 2 Clinical Study of NGM120 for the Treatment of Hyperemesis Gravidarum (HG) in Pregnant Patients Read More »
Neurona Unveils Phase 3 EPIC Study for NRTX-1001 Cell Therapy in Epilepsy Portfolio News / By Karina Tin Neurona Unveils Phase 3 EPIC Study for NRTX-1001 Cell Therapy in Epilepsy Read More »
Eikon Therapeutics Announces Nature Methods Publication Highlighting its Pioneering Oblique Line Scan Technology Portfolio News / By Karina Tin Eikon Therapeutics Announces Nature Methods Publication Highlighting its Pioneering Oblique Line Scan Technology Read More »
ORIC® Pharmaceuticals Reports Fourth Quarter and Full Year 2024 Financial Results and Operational Updates Portfolio News / By Karina Tin ORIC® Pharmaceuticals Reports Fourth Quarter and Full Year 2024 Financial Results and Operational Updates Read More »
